Inhibition of the recovery from potentially lethal damage by lonidamine
- PMID: 6208924
- PMCID: PMC1976972
- DOI: 10.1038/bjc.1984.232
Inhibition of the recovery from potentially lethal damage by lonidamine
Abstract
Lonidamine [1-(2,4-dichlorobenzyl)-1-H-indazol-3-carboxylic acid] is shown to inhibit recovery from potentially lethal damage after exposure of cells to X-rays, methyl methane sulfonate, or bleomycin and heat (43 degrees C, 1h). Inhibition is most effective when the drug is present before and after exposure of 10 to 25 mg l-1, a concentration readily achievable in vivo.
Similar articles
-
Recovery of cells from induced, potentially lethal damage.Cancer Treat Rep. 1976 Dec;60(12):1791-8. Cancer Treat Rep. 1976. PMID: 67891
-
Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems.Br J Cancer. 1983 Feb;47(2):221-31. doi: 10.1038/bjc.1983.30. Br J Cancer. 1983. PMID: 6824568 Free PMC article.
-
Morphological effects of lonidamine on two human-tumor cell culture lines.Scanning Microsc. 1989 Jun;3(2):681-91; discussion 691-3. Scanning Microsc. 1989. PMID: 2814409
-
Modulation of glycolysis in neuroepithelial tumors.J Neurosurg Sci. 1989 Jan-Mar;33(1):55-64. J Neurosurg Sci. 1989. PMID: 2674359 Review.
-
Lonidamine and related compounds.Prog Med Chem. 1984;21:110-35. Prog Med Chem. 1984. PMID: 6400133 Review. No abstract available.
Cited by
-
Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.Cancer Chemother Pharmacol. 1993;32(6):455-62. doi: 10.1007/BF00685890. Cancer Chemother Pharmacol. 1993. PMID: 8258194
-
Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma.Cancers (Basel). 2019 Feb 5;11(2):182. doi: 10.3390/cancers11020182. Cancers (Basel). 2019. PMID: 30764513 Free PMC article. Review.
-
Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.Cancer Chemother Pharmacol. 1989;25(1):32-6. doi: 10.1007/BF00694335. Cancer Chemother Pharmacol. 1989. PMID: 2590999
-
The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment.Cancers (Basel). 2020 Nov 11;12(11):3332. doi: 10.3390/cancers12113332. Cancers (Basel). 2020. PMID: 33187214 Free PMC article. Review.
-
Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.Br J Cancer. 1998;77(3):434-9. doi: 10.1038/bjc.1998.69. Br J Cancer. 1998. PMID: 9472640 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources